Product Categories
| Country: | China |
|---|---|
| Tel: | 021-18017925 |
| Mobile: | +8618916360931 |
| E-mail: | 2596183085@qq.com |
| QQ: | 2596183085 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| TCRS-417 | C25H19FN2O5 | 2032123-28-5 | Details |
| Antiulcer Agent 1 | C19H23N3O4 | 76001-09-7 | Details |
| 2-(pentylsulfanyl)pyrimidine-4,6-diol | C9H14N2O2S | 489403-70-5 | Details |
| α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid | C23H23NO3 | 128253-12-3 | Details |
| C14-4 | C84H173N5O7 | 2639634-80-1 | Details |
| Norspermine | C9H24N4 | 4605-14-5 | Details |
| BIBR 1087 SE | C32H37N7O5 | 212321-78-3 | Details |
| Rosiglitazone hydrochloride | C18H20ClN3O3S | 302543-62-0 | Details |
| CAY10703 HCl | 2193060-78-3 | Details |
| hCAII-IN-9 | C15H16ClN3O5S2 | 2878477-18-8 | Details |
| MK-2295 | C27H31FN6O2 | 878811-00-8 | Details |
| P-1075 | C12H17N5 | 60559-98-0 | Details |
| BRD4 Inhibitor 31 | C11H14N2O | 56369-21-2 | Details |
| Dopamine D2 receptor agonist-2 | C25H31Cl2N5OS | 1610591-93-9 | Details |
| AM-2232 | C24H20N2O | 335161-19-8 | Details |
| Bacopaside I | C46H74O20S | 382148-47-2 | Details |
| SRI 31215 TFA | C27H34F3N5O3 | 1832686-44-8 | Details |
| C20 Ceramide | C38H75NO3 | 7344-02-7 | Details |
| 8-Cyclopentyl-1,3-dimethylxanthine | C12H16N4O2 | 35873-49-5 | Details |
| (+)-JNJ-A07 | C28H26ClF3N2O6 | 2135640-93-4 | Details |
| 7-Troc-paclitaxel | C50H52Cl3NO16 | 114915-17-2 | Details |
| Pachybasin | C15H10O3 | 2549-78-2 | Details |
| (S)-ABT 102 | C21H24N4O | 808756-70-9 | Details |
| Sulfisoxazole acetyl | C13H15N3O4S | 80-74-0 | Details |
| Sigma-LIGAND-1 | C27H33NO4 | 139652-01-0 | Details |
| Antibacterial agent 171 | C18H21NO4S | 1354546-42-1 | Details |
| Iodipamide | C20H14I6N2O6 | 606-17-7 | Details |
| 1-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one | C17H19NO | 218934-50-0 | Details |
| C14 Ceramide (d18:1/14:0) | C32H63NO3 | 34227-72-0 | Details |
| UNC2881 | C25H33N7O2 | 1493764-08-1 | Details |
| Mudanpioside C | C30H32O13 | 172760-03-1 | Details |
| CPFX4158 | C51H55NO19 | 1804962-84-2 | Details |
| N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide | C13H8BrCl2NO2 | 1098360-68-9 | Details |
| TQS | C22H20N2O2S | 353483-92-8 | Details |
| Merodantoin | C11H18N2O2S | 143413-73-4 | Details |
| BRD4 Inhibitor 30 | C9H6FNOS | 1095051-79-8 | Details |
| m-PEG16-Br | C33H67BrO16 | 1238189-11-1 | Details |
| 5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole | C15H16BrN3O2 | 2863687-18-5 | Details |
| Tepoxalin | C20H20ClN3O3 | 103475-41-8 | Details |
| Pyrimorph | C22H25ClN2O2 | 868390-90-3 | Details |
| 4'-Methoxyflavanone | C16H14O3 | 97005-76-0 | Details |
| Anticancer agent 151 | C22H18Cl2N2O3 | 1227476-97-2 | Details |
| PDE4-IN-20 | C13H12F3N3O2 | 223500-15-0 | Details |
| Thalidomide-O-amido-PEG-C2-NH2 hydrochloride | C19H23ClN4O7 | 2204226-02-6 | Details |
| Almotriptan | C17H25N3O2S | 154323-57-6 | Details |
| TPN171 | C24H35N5O3 | 1229018-87-4 | Details |
| BMS-986224 | C24H23ClN4O6 | 2055200-88-7 | Details |
| Chymase-IN-1 | C20H15ClNO4PS | 862090-74-2 | Details |
| UZH2 | C27H37F2N7O | 2756566-45-5 | Details |
| Gemtuzumab | 2924764-21-4 | Details |
| MAO-B-IN-5 | C19H21FN2O2 | 849909-77-9 | Details |
| 2',3'-cGAMP sodium | C20H25N10NaO13P2 | 2734858-36-5 | Details |
| O-Propargyl-Puromycin | C24H29N7O5 | 1416561-90-4 | Details |
| Rolapitant hydrochloride | C25H27ClF6N2O2 | 858102-79-1 | Details |
| Golimumab | 476181-74-5 | Details |
| (+)-OSU 6162 | C15H23NO2S | 160777-43-5 | Details |
| ACT-1004-1239 | C27H28F2N6O3 | 2178049-58-4 | Details |
| CAY10784 | C11H6F3N3O3S | 1245814-52-1 | Details |
| FTX-6746 | C16H7ClF2N2O | 2829349-96-2 | Details |
| Urolithin M5 | C13H8O7 | 91485-02-8 | Details |
| CDFI | C28H28ClFN2 | 1199797-92-6 | Details |
| AG957 | C15H15NO4 | 140674-76-6 | Details |
| Viscumneoside III | C27H32O15 | 118985-27-6 | Details |
| ZYZ-488 | C20H29N3O11 | 1470302-79-4 | Details |
| RH1 | C12H14N2O3 | 221635-42-3 | Details |
| CWP232228 | C33H37N7NaO7P | 1144044-02-9 | Details |
| 1-Hydroxybaccatin I | C32H44O14 | 30244-37-2 | Details |
| AMPK activator 12 | C23H24BrNO2 | 431920-24-0 | Details |
| VA-K-14 hydrochloride | C18H16ClN3S | 1171341-19-7 | Details |
| Falintolol | C12H24N2O2 | 90581-63-8 | Details |
| Ipafricept | 1391727-24-4 | Details |
| Epaminurad HCl | C14H11Br2ClN2O3 | 1198153-46-6 | Details |
| PC190723 | C14H8ClF2N3O2S | 951120-33-5 | Details |
| 5-deoxy Thymidine | C10H14N2O4 | 3458-14-8 | Details |
| Baminercept | 909110-25-4 | Details |
| Paliroden | C26H24F3N | 188396-77-2 | Details |
| Rufigallol | C14H8O8 | 82-12-2 | Details |
| AVP-13358 | C30H29N5O2 | 459805-03-9 | Details |
| TGX-115 | C20H20N2O3 | 351071-62-0 | Details |
| DU717 | C12H15ClN4O2S | 59943-31-6 | Details |
| SMARCA-BD ligand 1 for Protac | C14H17N5O | 1997319-92-2 | Details |
| Dihydrodehydrodiconiferyl alcohol | C20H24O6 | 28199-69-1 | Details |
| GW-493838 | C21H21ClFN7O4 | 253124-46-8 | Details |
| Methotrexate Triglutamate | C30H36N10O11 | 41600-14-0 | Details |
| Plozalizumab | 1610761-46-0 | Details |
| LYP-IN-1 | C28H20ClNO6 | 1404436-51-6 | Details |
| Abagovomab | 792921-10-9 | Details |
| Prostaglandin E3 | C20H30O5 | 802-31-3 | Details |
| BI8622 | C25H26N6O | 1875036-74-0 | Details |
| MMP-2/MMP-9 Inhibitor I | C21H19NO4S | 193807-58-8 | Details |
| JNJ-20788560 | C25H28N2O2 | 825649-28-3 | Details |
| Dichlorisone Acetate | C23H28Cl2O5 | 79-61-8 | Details |
| Pomalidomide-amino-PEG3-NH2 hydrochloride | C21H27ClN4O8 | 2380273-75-4 | Details |
| JNK-IN-11 | C12H11NO3S2 | 676594-38-0 | Details |
| Etarotene | C25H32O2S | 87719-32-2 | Details |
| Mal-amido-PEG12-NHS ester | C38H63N3O19 | 2101722-60-3 | Details |
| SSD114 HCl | C18H21ClF3N3O | 2319790-02-6 | Details |
| Org-26576 | C11H12N2O2 | 1026791-61-6 | Details |
| Pomalidomide-PEG4-C2-NH2 | C23H32N4O8 | 2225940-52-1 | Details |
| Impromidine hydrochloride | C14H24ClN7S | 65573-02-6 | Details |
| Product Total： Product Page： | ||||
| 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 | ||||